MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 246 filers reported holding MIRATI THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $229 | -42.0% | 6,350 | -40.2% | 0.02% | -59.5% |
Q1 2023 | $395 | -99.9% | 10,623 | +12.7% | 0.04% | -30.0% |
Q3 2022 | $658,000 | -2.7% | 9,423 | -6.4% | 0.06% | +5.3% |
Q2 2022 | $676,000 | -45.0% | 10,070 | +32.4% | 0.06% | -52.1% |
Q2 2021 | $1,229,000 | +196.9% | 7,607 | +303.3% | 0.12% | +164.4% |
Q4 2020 | $414,000 | -46.1% | 1,886 | -59.2% | 0.04% | -65.9% |
Q3 2020 | $768,000 | +161.2% | 4,627 | +22.5% | 0.13% | +473.9% |
Q3 2019 | $294,000 | +12.6% | 3,776 | +6.1% | 0.02% | +53.3% |
Q1 2019 | $261,000 | – | 3,558 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |